Most adults lose between 15% and 22.5% of their body weight on Zepbound (tirzepatide) over 72 weeks, depending on the dose. At the highest dose of 15 mg, participants in the SURMOUNT-1 trial lost an average of 22.5% of their body weight, which is the largest average weight loss recorded for any single anti-obesity medication.

Clinical Trial Results for Zepbound

Zepbound was approved by the FDA in November 2023 for chronic weight management. It contains tirzepatide, a dual GIP/GLP-1 receptor agonist that activates two incretin pathways simultaneously. This dual mechanism is believed to drive the greater weight loss observed compared to single-agonist GLP-1 medications like semaglutide.

SURMOUNT-1: The Pivotal Trial

SURMOUNT-1 enrolled 2,539 adults with obesity (BMI 30+) or overweight (BMI 27+) with at least one weight-related condition, without diabetes. All participants received lifestyle counseling. Results at 72 weeks:

• Zepbound 5 mg: 15.0% average body weight loss
• Zepbound 10 mg: 19.5% average body weight loss
• Zepbound 15 mg: 22.5% average body weight loss
• Placebo: 3.1% average body weight loss

At the 15 mg dose:

• 96% of participants lost at least 5% of body weight
• 84% lost at least 10%
• 63% lost at least 20%
• 36% lost 25% or more

SURMOUNT-2: Results in People With Diabetes

SURMOUNT-2 studied Zepbound in 938 adults with both obesity and type 2 diabetes. At 72 weeks:

• Zepbound 10 mg: 12.8% average weight loss
• Zepbound 15 mg: 14.7% average weight loss

Weight loss is consistently lower in patients with diabetes across all GLP-1 class medications, but these results still represent clinically meaningful outcomes.

SURMOUNT-4: What Happens After Stopping

SURMOUNT-4 gave all participants Zepbound for 36 weeks, then randomized them to continue or switch to placebo. Those who continued Zepbound lost an additional 5.5% of body weight over the next year. Those switched to placebo regained approximately 14 percentage points, ending up having kept only about half their initial weight loss. This trial clearly demonstrated the need for ongoing treatment.

What That Means in Real Numbers

At the 15 mg dose (22.5% average loss):

• Starting at 200 pounds: approximately 45 pounds lost
• Starting at 250 pounds: approximately 56 pounds lost
• Starting at 300 pounds: approximately 68 pounds lost

At the 10 mg dose (19.5% average loss):

• Starting at 200 pounds: approximately 39 pounds lost
• Starting at 250 pounds: approximately 49 pounds lost
• Starting at 300 pounds: approximately 59 pounds lost

Weight Loss Timeline

Zepbound follows a gradual dose escalation over at least 20 weeks:

• Weeks 1-4 (2.5 mg): Starting dose for tolerability. Expect 2-5 pounds of weight loss.
• Weeks 5-8 (5 mg): First therapeutic dose. Weight loss becomes more noticeable.
• Weeks 9-20 (escalation through 7.5, 10, 12.5, 15 mg): Rapid weight loss phase. Many patients see 8-12% body weight loss by week 20.
• Weeks 20-72 (maintenance dose): Continued weight loss at a gradually decreasing rate. Most of the total result is achieved by months 12-15.

What Influences Your Personal Outcome

• Dose level: There is a clear dose-response relationship. The 15 mg dose produces about 50% more weight loss than 5 mg. Your physician will titrate based on your tolerance and response.
• Diabetes: Having type 2 diabetes reduces expected weight loss by approximately 6-8 percentage points at the same dose.
• Diet and exercise: All trial participants received structured lifestyle counseling. Real-world results depend heavily on dietary adherence and activity level.
• Consistency: Missing doses disrupts the medication's sustained effect on appetite and metabolism.
• Biological factors: Individual genetics, gut microbiome composition, and baseline hormone levels all contribute to how strongly any person responds to tirzepatide.

What to Consider

Zepbound's clinical trial results are impressive, but they represent averages. Some patients exceed 30% weight loss while others may lose less than 10%. Your physician can help you set appropriate expectations based on your health profile, starting weight, and other factors.

The dose titration period takes at least 20 weeks, so patience during the early months is important. Gastrointestinal side effects such as nausea are most common during dose increases and typically improve once a stable dose is reached.

Zepbound is designed for long-term use. SURMOUNT-4 data clearly showed that stopping the medication leads to substantial weight regain. A sustainable, long-term treatment plan should be part of your initial conversation with your physician.

Related Questions

Is Zepbound better than Wegovy for weight loss?

In indirect comparisons across separate trials, Zepbound at 10-15 mg produced greater weight loss (19.5-22.5%) than Wegovy at 2.4 mg (14.9%). The SURMOUNT-5 head-to-head trial confirmed that tirzepatide 15 mg produced significantly more weight loss than semaglutide 2.4 mg. However, individual responses vary, and the best medication depends on your specific health profile and tolerance.

How much weight do you lose on Zepbound in the first month?

During the first month on the 2.5 mg starting dose, most patients lose between 3 and 6 pounds. This initial phase is primarily about building tolerance to the medication before dose escalation. The most significant weight loss occurs during months 2-10 as the dose is increased.

Can Zepbound help me lose 50 pounds?

Losing 50 pounds is realistic for many Zepbound patients, particularly those with higher starting weights. A person starting at 230 pounds would need to lose about 22% of body weight to reach a 50-pound loss, which aligns with the average result at the 15 mg dose. Those starting at lower weights may find 50 pounds less achievable.

Does Zepbound work better than diet and exercise alone?

Yes, substantially. The placebo group in SURMOUNT-1 (which received diet and exercise counseling without medication) lost an average of 3.1% of body weight. Zepbound groups lost 15-22.5% at the same time. However, Zepbound is intended to be used alongside dietary changes and physical activity, not as a replacement for them.

Start Your Zepbound Journey with FormBlends

FormBlends provides physician-supervised tirzepatide therapy with personalized dosing, regular check-ins, and comprehensive medical support. Every treatment plan starts with a thorough evaluation to ensure Zepbound is safe and appropriate for you. Start your consultation today.